Evidence map›Paper›PMID 32185220›Full record

ArticleBioMed research international2020

Szymon Zmorzyński, Magdalena Wojcierowska-Litwin, Małgorzata Kowal, Małgorzata Michalska-Jakubus, Wojciech Styk, Agata Anna Filip, Irena Walecka, Dorota Krasowska

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BioMed research international, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Szymon ZmorzyńskiDepartment of Cancer Genetics with Cytogenetic Laboratory, Medical University of Lublin, Lublin, Poland.ORCID https://orcid.org/0000-0002-2039-2908
Magdalena Wojcierowska-LitwinDepartment of Cancer Genetics with Cytogenetic Laboratory, Medical University of Lublin, Lublin, Poland.
Małgorzata KowalChair and Department of Dermatology, Venerology and Pediatric Dermatology, Medical University of Lublin, Lublin, Poland.
Małgorzata Michalska-JakubusChair and Department of Dermatology, Venerology and Pediatric Dermatology, Medical University of Lublin, Lublin, Poland.
Wojciech StykInstitute of Psychology, The John Paul II Catholic University of Lublin, Lublin, Poland.ORCID https://orcid.org/0000-0003-0186-3118
Agata Anna FilipDepartment of Cancer Genetics with Cytogenetic Laboratory, Medical University of Lublin, Lublin, Poland.
Irena WaleckaDepartment of Dermatology, Centre of Postgraduate Medical Education, Warsaw, Poland.
Dorota KrasowskaChair and Department of Dermatology, Venerology and Pediatric Dermatology, Medical University of Lublin, Lublin, Poland.
Medical University of Lublin · PLJohn Paul II Catholic University of Lublin · PLPostgraduate School of Molecular Medicine · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

resultsThe genotypic frequencies of the

conclusionThe CT + CC genotypes of

Indexed as

AdolescentAdultAgedAutoantibodiesDisease SusceptibilityFemaleGene FrequencyGenetic Predisposition to DiseaseGenotypeHumansLung Diseases, InterstitialMaleMiddle AgedPolymorphism, Single NucleotideReceptor, Notch3Scleroderma, DiffuseAutoantibodiesNOTCH3 protein, humanReceptor, Notch3TP53 protein, humanTumor Suppressor Protein p53

Identifiers

PMID32185220
PMCPMC7060860
OpenAlexW3008411584

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.